IMMUNE STATUS

Microbiologist                      Beth White            (307) 777-6063
Microbiologist               Claudia Rogers            (307) 777-6061

 

Rubella        (German Measles)                     Mumps

Rubeola       (Hard Measles)                         Hepatitis B Surface Antibody

Varicella       (Chickenpox)

 

Rubella, Rubeola, Varicella zoster, Mumps 

TYPE OF TEST

Automated enzyme-linked fluorescent immunoassay (ELFA) for the qualitative detection of IgG antibodies.

SPECIMEN REQUIREMENTS

Serum (minimum of 2.0 ml of serum or 3.0 ml of whole blood).  Do not use grossly lipemic, hemolyzed, or icteric serum.  The use of plasma has not been established for this test.

SHIPPING REQUIREMENTS

Ship according to regulations for infectious substances.  Complete and enclose test request form.

If you cannot send the specimen on the day of collection, please refrigerate the sample after it has clotted.

Specimens received later than 14 days after the draw will be rejected.

DAYS TEST PERFORMED

Tuesday and Friday.

RESULTS AVAILABLE

Results are mailed upon completion.

REPORTING & INTERPRETATION

Results will be reported as Positive (prior exposure and/or immunity), NEGATIVE (no prior exposure and/or no immunity), and EQUIVOCAL (immunity cannot be determined).

ADDITIONAL COMMENTS

Please provide an adequate volume of the specimen for test completion. 

Overly hemolyzed specimens will be rejected. 

 

 


 

 

Hepatitis B Surface Antibody

TYPE OF TEST

EIA for the presence of Hepatitis B Surface Antibody (HbsAb).

SPECIMEN REQUIREMENTS

Submit 7 ml of whole blood in a red top or tiger top tube or 2 ml of serum.

SHIPPING REQUIREMENTS

Place specimen in biohazard bag with completed requisition in the outside pocket.  Package in mailers provided by WPHL or comparable approved shipping container.  Ship as diagnostic specimen, following USPS or carrier shipping regulations.

DAYS TEST PERFORMED

Tuesday and Thursday.

RESULTS AVAILABLE

Results are mailed upon completion.

REPORTING & INTERPRETATION

Results are reported as REACTIVE, BORDERLINE, or NON-REACTIVE.

REACTIVE indicates the presence of antibody as a result of a previous Hepatitis B infection or vaccination series and the patient is considered immune.

BORDERLINE indicates borderline status and interpretation should be based on other clinical information or subsequent testing.

NONREACTIVE indicates non-detectable or absent levels of antibody.  If the patient is known to have vaccinated against Hepatitis B, their antibody levels may be present, but non-detectable.

ADDITIONAL COMMENTS

Results are qualitative and are not reported as quantitative titers. 

 

 

Return to Microbiology